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A B S T R A C T
Rationale and objective: Oesophageal cancer shows marked geographic variations and is one of the leading
causes of cancer death worldwide. We described the burden of this malignancy in Central and South
America.
Methods: Regional and national level incidence data were obtained from 48 population-based cancer
registries in 13 countries. Mortality data were obtained from the WHO mortality database. Incidence of
oesophageal cancer by histological subtype were available from high-quality population-based cancer
registries.
Results: Males had higher incidence and mortality rates than females (male-to-female ratios: 2–6:1 and
2–5:1). In 2003–2007, the highest rates were in Brazil, Uruguay, Argentina and Chile. Mortality rates
followed the incidence patterns. Incidence of oesophageal squamous cell carcinoma (SCC) was higher
than adenocarcinoma (AC), except in females from Cuenca (Ecuador). SCC and AC incidence were higher
in males than females, except in the Region of Antofagasta and Valdivia (Chile), Manizales (Colombia) and
Cuenca (Ecuador). Incidence and mortality rates tended to decline in Argentina, Chile, Brazil (incidence)
and Costa Rica from 1997 to 2008.
Conclusion: The geographic variation and sex disparity in oesophageal cancer across Central and South
America may reﬂect differences in the prevalence of tobacco smoking and alcohol consumption which
highlights the need to implement and/or strengthen tobacco and alcohol control policies. Maté
consumption, obesity, diet and Helicobacter pylori infection may also explain the variation in oesophageal
cancer rates but these relationships should be evaluated. Continuous monitoring of oesophageal cancer
rates is necessary to provide the basis for cancer prevention and control in the region.
ã 2015 International Agency for Research on Cancer; Licensee Elsevier Ltd. This is an open access article
under the CC BY-NC-ND IGO 3.0 license (https://creativecommons.org/licenses/by-nc-nd/3.0/igo/).
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Esophageal cancer is the eighth most common malignancy
diagnosed and the sixth leading cause of cancer death in the world
[1,2]. Early diagnosis of esophageal cancer is unusual and survival
is very poor [3,4]. In 2012, approximately 456,000 new esophageal
cancer cases and 400,000 cancer deaths were estimated to occur$ This is an Open Access article published under the CC BY NC ND 3.0 IGO license
which permits users to download and share the article for non-commercial
purposes, so long as the article is reproduced in the whole without changes, and
provided the original source is properly cited. This article shall not be used or
reproduced in association with the promotion of commercial products, services or
any entity. There should be no suggestion that IARC endorses any speciﬁc
organisation, products or services. The use of the IARC logo is not permitted. This
notice should be preserved along with the article’s original URL.
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creativecommons.org/licenses/by-nc-nd/3.0/igo/).globally. More than 80% (370,000 new cases and 329,000 deaths) of
all esophageal cancer cases were estimated to occur in less-
developed regions and less than 20% (86,000 new cases and
71,000 deaths) in more-developed regions of the world. Approxi-
mately 4% (20,000 new cases and 16,000 deaths) of the global
burden of esophageal cancer was estimated to occur in the Central
and South American region [1].
There is a striking geographical variation in the incidence and
mortality of esophageal cancer and a noticeable difference
between males and females [1,2]. For example, high-incidence
areas can be identiﬁed in Iran and in some parts of China and
Zimbabwe; intermediate-incidence areas in East Africa, South
America, the Caribbean, most parts of China, Central Asia, northern
India, and southern Europe; and low-incidence areas in North
America, northern Europe, and western Africa [2]. Male-to-female
ratios are between 1.2–9 for incidence and 2.3–13 for mortality [5].
Most esophageal cancers can be classiﬁed into squamous-cell
carcinoma (SCC) or adenocarcinoma (AC) [2,3] which have. This is an open access article under the CC BY-NC-ND IGO 3.0 license (https://
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major risk factors for SCC are smoking and alcohol use, also
thermal trauma caused by hot or very hot beverages; the main risk
factors for AC are smoking, overweight/obesity and gastroesopha-
geal reﬂux (GORD) [2,6,8,9]. There are considerable variations in
the global distribution of esophageal SCC and AC. Both subtypes
occur more frequently in men than women; however, SCC occurs
more frequently among individuals in low-resource regions, while
AC is more frequent in high-resource populations [2]. Recent
estimates indicate that the global burden of esophageal SCC is
located mainly in South-Eastern and Central Asia and Latin
America (accounting for 79% and 4.1% of the SCC global burden,
respectively), whereas the global burden of esophageal AC is
located mainly in Northern and Western Europe, North America
and Oceania (46% of the total global AC burden) [10].
Rapid increases in the incidence of esophageal cancer have been
observed in some high-income countries over the last three
decades [11–14]. Although a decline has also been reported in the
United States in recent years [15], this is speciﬁcally in the
incidence of SCC, and is thought to be due to declines in the
prevalence of smoking. The rapid increase in AC incidence,
observed in the United States and other Western countries, is
probably related to increases in the prevalence of GORD and
obesity [13,16–18]. However, the reasons for this remain poorly
understood [10]. Mortality rates have stabilized or declined in
several regions of the world [14], including Central and South
America [14,19,20]. However, in Cuban and Mexican males,
mortality has increased in recent decades [19,20]. Recent estimates
revealed that the burden of esophageal cancer will increase in
Central and South America by almost 80% by the year 2030
(35,000 new cases and 29,000 deaths) due to ageing and growth of
the population [1].
Although a few studies of incidence and (mainly) mortality
from esophageal cancer conducted in the Central and South
American region have shown an important geographic variation
across countries, with some declines in mortality rates [14,19–25],
a detailed description of the patterns of esophageal cancer
incidence by histological subtype is lacking. In this paper we
describe the geographic and temporal trends in incidence and
mortality of esophageal cancer in the Central and South American
region, including a distinction by histology. We also review the
epidemiology of this disease and focus on tobacco and alcohol
consumption, the two major risk factors, and brieﬂy discuss the
current status of tobacco and alcohol control policies.
2. Methods
The present analysis includes esophageal cancer (C15), as coded
by the 10th edition of the International Classiﬁcation of Diseases
for Oncology (ICD-10). The data sources and methods are described
in detail in an earlier article in this issue. In brief, from the
22 countries located in Central and South America (including
Cuba), we obtained regional- and national-level incidence data
from 48 population-based cancer registries in 13 countries and
cancer deaths from the World Health Organization mortality
database for 18 countries. Age-standardized incidence rates (ASRs)
and mortality rates (ASMRs) per 100,000 person-years wereTable 1
Countries included in the analysis of time trends.
Country Name of registries included 
Argentina Bahia Blanca 
Brazil Aracaju, Fortaleza, Goiania, Sao Paulo 
Chile Valdivia 
Costa Rica National registry calculated using the direct method and the World standard
population [26,27]. National ASRs were estimated by data
aggregation from the available cancer registries using a weighted
average of local rates. To describe incidence and mortality time
trends, estimated annual percentage change (EAPC) was calculated
using the method proposed by Esteve et al. [28]. Registries that
provided formal consent to use data by individual year of diagnosis
for 10-years were included in the time-trend analysis. Trends in
incidence and mortality and EAPCs were estimated for four
countries (Table 1). All of the EAPCs were tested for equality to zero
by using the corresponding standard errors. EAPC was considered
statistically signiﬁcant if the P-value 0.05. Data analyses were
performed in Stata version 12.1 (StataCorp) [29].
Histological subtype information was extracted from ICD-O-
3 codes from each registry. However, due to the large proportion of
cases classiﬁed as “other” and “unspeciﬁed” (range 0–30%) we
decided to present the incidence rates by histological subtype from
high-quality population-based cancer registries published in
Cancer Incidence in Five Continents (CI5) volume X [30].
3. Results
3.1. Age-standardized incidence and mortality rates
Although esophageal cancer is still a relatively rare diagnosis in
Central and South America, it is one of the ﬁve most frequent
causes of death due to cancer among males in Brazil, Belize,
Paraguay, and Uruguay (Table 2). Overall, males had incidence and
mortality rates 3 times higher than those in females (male-to-
female ratios ranging from: 2 to 6:1 and 2 to 5:1, respectively).
During the most recent period (i.e. 2003–2007), the highest
incidence rates of esophageal cancer among males and females
were observed in the Southern Cone of South America: Brazil
(10.1 and 2.3, respectively), Uruguay (8.8 and 2.7), Argentina
(7.5 and 2.5) and Chile (6.1 and 3.1). The lowest incidence rates in
both sexes were in Bolivia, El Salvador and Mexico (rates 1.1 for
males and 0.4 for females) (Tables 2 and 3). Mortality rates
closely followed the incidence patterns, with the highest rates
observed in males and females in Uruguay (8.3 and 2.2), Argentina
(7.5 and 1.8), Brazil (6.6 and 1.6) and Chile (5.2 and 2.3). Nicaragua
had the lowest mortality rates in the region (0.76 for males and
0.26 for females).
3.2. Time trends
Declines in esophageal cancer incidence and mortality rates
were observed among males and females in Argentina (1998–
2007), Chile (1997–2008) and Costa Rica (1985–2007) since the
mid-1990s (Fig. 1). In the most recent 10-year period, the largest
declines in incidence of esophageal cancer were observed in males
in Chile, Argentina and Brazil (EAPCs: 3.0, 2.3, and 2.1,
respectively, P > 0.05) whereas the highest declines in mortality
were in Chile and Argentina (EAPCs: 3.8 and 2.1, respectively,
P > 0.05). In females, the largest declines in incidence were in
Argentina, Chile, and Costa Rica (EAPCs: 10.6, 5.8, and 5.7,
respectively, P > 0.05) while the highest declines in mortality werePeriod % of the population covered
1993–2007 0.8
1997–2006 8.0
1993–2008 2.2
1985–2007 100.0
Table 2
Age-standardized incidence and mortality rates (per 100,000) from oesophageal cancer in Central and South America, all ages.
Country (period) Incidence Mortality
Sex Cases ASR (W) MV% Ranka M:F Deaths ASR (W) Ranka M:F
CENTRAL AMERICA
Belize (2003–07) M 11 3.0 5 4.2
F 3 0.7 15
Costa Rica (2003–07) M 189 2.2 74 17 3.8 185 2.0 12 3.9
F 63 0.6 52 23 57 0.5 20
Cubab (2004–07) M 117 4.5 61 13 4.2 1659 5.5 7 4.4
F 30 1.1 70 23 438 1.2 16
El Salvadorb (1999–03) M 64 0.6 77 8 1.9 165 1.5 11 2.4
F 44 0.3 86 11 86 0.6 17
Guatemala (2003–07) M 282 1.6 9 2.0
F 167 0.8 11
Mexicob (2006–10) M 146 1.1 100 18 3.9 3328 2.0 12 3.3
F 43 0.3 100 23 1213 0.6 19
Nicaragua (2003–07) M 58 0.8 13 2.9
F 24 0.3 17
Panama (2003–07) M 143 2.1 10 3.8
F 40 0.6 17
SOUTH AMERICA
Argentinab (2003–07) M 954 7.5 68 9 3.1 6647 6.1 6 3.5
F 436 2.5 68 18 2887 1.8 13
Boliviab (2011) M 12 1.0 83 11 2.6
F 6 0.4 100 21
Brazilb (2003–07) M 4280 10.1 78 8 4.3 25092 6.6 4 4.1
F 1381 2.3 77 20 7465 1.6 11
Chileb (2003–07) M 128 6.1 78 10 1.9 2200 5.2 7 2.3
F 87 3.1 75 17 1418 2.3 12
Colombiab (2003–07) M 244 3.0 87 16 2.1 2270 3.1 9 2.6
F 159 1.4 79 22 1144 1.2 13
Ecuadorb (2003–07) M 83 2.0 82 18 3.2 339 1.3 9 3.3
F 29 0.6 79 21 115 0.4 17
French Guyanab (2003–08) M 20 6.8 100 8 6.3
F 4 1.1 100 22
Paraguay (2003–07) M 326 3.3 5 4.4
F 88 0.8 13
Perub (2001–05) M 153 1.8 76 18 3.7 531 1.1 11 2.9
F 52 0.5 75 23 209 0.4 18
Suriname (2003–07) M 18 1.9 9 5.4
F 4 0.4 18
Uruguay (2005–07) M 596 8.8 72 11 3.3 578 8.3 5 3.8
F 281 2.7 68 18 252 2.2 11
Venezuela (2003–07) M 941 2.0 11 3.3
F 337 0.6 17
ASR (W), age-standardized (World population) rate per 100,000; M, males, F; females; M:F, male-to-female ratio.
a Rank across cancer types, based on highest ASR excluding: all sites but C44 and All sites.
b Incidence rates were estimated using aggregated data from regional cancer registries.
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P > 0.05) (Fig. 2).
3.3. Incidence by histological subtype
Esophageal squamous-cell carcinoma (SCC) was the predomi-
nant histologic subtype in most populations, accounting for about
70% of all esophageal cancers detected in the region (Annex
Table A1). Overall, SCC incidence rates among males and females
were remarkably higher than the rates for any other histologic
subtypes, except in females from Cuenca (Ecuador) where AC the
subtype was the highest (Tables 3 and 4). Incidence rates of SCC
and AC in males were higher than in females (male-to-female
ratios: 2–7:1 and 1.5–11:1, respectively), except in Manizales(Colombia) where the male-to-female ratio for SCC was 1:0.4, and
for Cuenca (Ecuador) where the male-to-female ratio for AC was
0.3:1.
3.4. Current tobacco and alcohol prevalence and public health policies
Tobacco smoking and alcohol consumption are preventable
factors associated with an increased risk of esophageal cancer;
speciﬁcally, tobacco smoke is causally related to SCC and AC, while
alcohol consumption is causally associated with SCC and has little
to no association with AC [8,31].
According to the 2013 report of the WHO [32], the prevalence of
smoking among men in the Central and South American region was
1.2–9 times higher than in women (12 years and older) [32].
Table 3
Age-standardized incidence rates (per 100,000) of microscopically veriﬁed cases of esophageal cancer within Central and South American registries in Cancer Incidence in
Five Continents, Volume X [30], males, all ages.
Country Registry Carcinoma Sarcoma Other Unspec Number of cases
Squamous Adeno Other Unspec MV Total
Argentina Bahia Blanca 3.0 0.9 – 0.6 – – 0.1 44 56
Cordoba 3.1 1.5 – 0.3 – 0.0 0.0 133 164
Mendoza 3.0 1.5 – 0.7 – – 0.1 240 294
Tierra del Fuego 4.8 2.2 – 0.8 – – – 13 16
Brazil Aracaju 3.2 – 0.2 – – – – 19 21
Belo Horizonte 7.6 0.1 0.0 0.3 – – 0.4 220 251
Cuiaba 5.1 0.9 – 0.7 – – 0.5 63 76
Fortaleza 4.6 0.8 0.1 0.2 – – 0.3 159 184
Goiania 9.2 0.3 0.1 0.1 – – 0.2 197 214
Sao Paulo 5.9 1.8 0.0 0.8 0.0 0.0 0.0 1855 2375
Chile Region Antofagasta 1.9 1.0 – 0.4 0.1 – 0.1 36 54
Biobio 7.2 – – – – – – 75 103
Valdivia 3.9 1.4 0.2 0.4 0.1 0.1 – 64 74
Colombia Bucaramanga 2.1 1.1 – 0.1 – – 0.0 71 83
Cali 1.3 1.0 – 0.1 – – 0.0 104 120
Manizales 0.7 0.6 – 0.2 – – – 14 18
Pasto 2.0 0.4 – 0.3 – – 0.2 22 23
Costa Rica Costa Rica 0.9 0.6 0.0 0.1 – 0.0 0.1 140 189
Cuba Villa Clara 1.8 0.6 – 0.4 – – 0.1 71 117
Ecuador Cuenca 0.7 0.1 0.2 – – – – 8 12
Quito 1.2 0.5 – 0.2 0.0 – – 60 71
Uruguay Uruguay 4.4 1.4 0.1 0.5 – 0.0 0.0 428 596
Adeno, adenoma; Unspec, unspeciﬁed; MV, microscopic veriﬁcation,  (dash), no cases registered; 0.0, the rate is >0 but <0.05.
Italics: rates based on less than 10 cases are in italics.
Fig. 1. Trends in esophageal cancer, all ages.
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Fig. 2. Estimated annual percentage change in age-standardized incidence and mortality rates (per 100,000) from esophageal cancer.
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Chile (40.6%), followed by Uruguay, Cuba, Ecuador, Argentina, and
Venezuela (21–25%); Costa Rica, El Salvador, and Belize had the
lowest smoking prevalence (10.2–12.8%). The WHO developed the
Framework Convention of Tobacco Control to reduce the preva-
lence of smoking and exposure to tobacco smoke by about a third
by 2025 [32]. As of June 2004, all countries in the Central and South
American region have signed the WHO Framework Convention of
Tobacco Control; between May 2004 and July 2014 all countries in
the region ratiﬁed the framework, except for Argentina, El Salvador
and Cuba which signed but did not ratify it [33,34]. Brazil and
Uruguay have implemented some of the strongest tobacco-
smoking policies in the Central and South America and the
prevalence of smoking has declined in recent years [35,36].
According to the 2014 report of the WHO [37], the region of the
Americas has the second highest alcohol consumption per capita in
the world, after Europe (8.4 l of pure alcohol per capita per year). In
Central and South America (respectively), Costa Rica, Cuba, and
Nicaragua and Chile, Argentina, and Venezuela had the highest
alcohol consumption (annual per capita alcohol consumption of:
5–5.4 and 8.9–9.6 l of pure alcohol, respectively) and men
consumed approximately 2–4 times more alcohol than women.
The WHO’s Substance Abuse Department (WHO/SAB) [37] made
the prevention and reduction of the harmful use of alcohol a public
health priority in 2010, and member states have endorsed the
global strategy to reduce the harmful use of alcohol. In the Central
and South American region, only Argentina, Brazil, Chile, Colombia,Cuba, and Mexico have written a national policy and have a
national action plan, while Paraguay and Venezuela have written a
national policy but do not have a national action plan.
4. Discussion
Esophageal cancer incidence and mortality rates show a wide
variation within countries in Central and South America (incidence
varied by 10-fold in males and 6-fold in females, and mortality
varied by 11-fold in males and 8-fold in females), with the highest
rates observed in Argentina, Brazil, Chile and Uruguay. We also
observed a remarkable sex disparity in esophageal cancer rates in
the region. Geographic variations in esophageal cancer rates as
well as sex differences have been described across different regions
of the world [14,16–18,20,24,38,39]. These differences in esoph-
ageal cancer incidence and mortality rates are likely to reﬂect, to a
large extent, differences in the prevalence of smoking and alcohol
use [21,40].
Even though we estimated national incidence rates based on
aggregated data from regional registries, our results were
comparable with the national data from Cuba and with central-
western Brazil (Goiania, Brasilia, and Cuiaba) [38,41]. However, our
rates were slightly lower than the estimates for Colombia for 1995–
1999 [39], which may, in part, reﬂect changes in the smoking
prevalence from the periods evaluated. Comparable or slightly
lower mortality rates have also been reported in different countries
and areas of the Central and South American during different
Table 4
Age-standardized incidence rates (per 100,000) of microscopically veriﬁed cases of esophageal cancer within Central and South American registries in Cancer Incidence in
Five Continents, Volume X [30], females, all ages.
Country Registry Carcinoma Sarcoma Other Unspec Number of cases
Squamous Adeno Other Unspec MV Total
Argentina Bahia Blanca 1.0 0.1 – 0.1 – – 0.0 18 25
Cordoba 1.4 0.4 0.0 0.1 – – 0.0 74 96
Mendoza 1.3 0.3 – 0.2 – – 0.0 103 132
Tierra del Fuego 0.7 0.4 – – – – – 2 2
Brazil Aracaju 1.2 – – 0.2 – – – 12 12
Belo Horizonte 1.9 0.0 – 0.0 – – 0.1 80 101
Cuiaba 1.6 0.3 0.1 0.1 – – – 21 23
Fortaleza 1.6 0.1 0.0 0.1 – – 0.1 77 93
Goiania 2.0 – – 0.1 – – 0.2 57 65
Sao Paulo 1.1 0.5 0.0 0.2 0.0 – 0.0 544 693
Chile Region Antofagasta 0.9 0.7 – 0.1 – – – 22 38
Biobio 2.7 – – 0.1 – – 0.1 34 46
Valdivia 2.5 0.2 0.1 0.2 – – – 43 49
Colombia Bucaramanga 0.6 0.1 – 0.0 – – 0.0 23 34
Cali 0.8 0.3 – 0.1 – – 0.0 65 82
Manizales 1.6 0.4 – 0.3 – – 0.1 28 30
Pasto 0.6 0.3 – – – – – 10 13
Costa Rica Costa Rica 0.2 0.1 – 0.0 – 0.0 0.0 33 63
Cuba Villa Clara 0.5 0.0 – 0.2 – – 0.0 21 30
Ecuador Cuenca 0.1 0.3 – – – – – 4 6
Quito 0.4 0.2 – – – – – 19 23
Uruguay Uruguay 1.4 0.4 0.0 0.1 – 0.0 – 192 281
Adeno, adenoma; Unspec, unspeciﬁed; MV, microscopic veriﬁcation, – (dash), no cases registered; 0.0, the rate is >0 but <0.05.
Italics: rates based on less than 10 cases are in italics.
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areas), Colombia, Costa Rica, Cuba, Ecuador, Mexico, Venezuela and
Uruguay [19,24,38,39].
We observed that incidence and mortality rates from esoph-
ageal cancer tended to decline in Argentina, Brazil (incidence),
Chile and Costa Rica from 1997 to 2008 for both sexes, although
this was not statistically signiﬁcant. Likewise, declines in incidence
have been reported in Costa Rican females, whereas in males rates
increased from 1980 to 2000 [21]. Declines in incidence have been
described in Cali (1984–2008) and Pasto (1998–2002), Colombia, in
males but not in females [22,23]. Declines in esophageal cancer
incidence rates have also been reported in Western populations
like the United States (except in Whites) in 1997–2005 [16].
Consistent with our observations, declines in mortality rates
have also been reported in Argentina and Uruguay from 1990 to
2005 [24]. Conversely, increases in mortality have been described
among Cuban males (1970–2000) and females (1987–2008), while
some declines have been observed in Colombia, Costa Rica,
Ecuador, Mexico and Venezuela in both males and females since
the 1970s and 1980s [20,25,42].
The declines in esophageal cancer rates are thought to reﬂect
the changes in the prevalence of two major factors associated with
this disease (tobacco smoke, alcohol use) [13,16,25,43,44]. For
instance, the strikingly low incidence and mortality rates observed
in Costa Rica may reﬂect the low prevalence of smoking in the
country, particularly among females (8%), compared to the high
incidence rates observed in other Central and South American
countries (Cuba, Argentina, Brazil, and Uruguay) where tobacco
prevalence among females is higher (ranging from 13% to 21%)
[32,45]. In Cuba, about 70% and 80% of the esophageal cancer
deaths reported in 1995 and 2007 were attributed to smoking (79%
and 82% among males, and 76% and 69% among females,
respectively) [46].Esophageal SCC was the most frequently diagnosed histological
subtype in Central and South America, followed by AC. Both SCC
and AC showed remarkable geographic variation. As expected,
males had higher SCC rates than females, with a few exceptions.
For example, compared to males, females had higher incidence
rates of SCC in Manizales (Colombia) and higher rates of AC in
Cuenca (Ecuador); if this sex difference is not due to under-
registration, differences in tobacco uptake among females may
partially explain this pattern. Similar sex differences have been
reported in the United States, Australia, and Singapore [16,18,43].
These geographic differences in esophageal SCC and AC can
identify important clues about their etiology, as the major risk
factors associated with SCC are smoking and alcohol use, thermal
trauma (caused by consumption of hot or very hot beverages)
whereas the main factors for AC are smoking, overweight and
obesity, and gastroesophageal reﬂux disease (GORD) [2,6,47,48].
In a multicenter case–control study conducted in Argentina,
Brazil, Paraguay and Uruguay, Castellsague et al. [49] found that
simultaneous tobacco and alcohol use increased the risk of
esophageal SCC by 8-fold when compared to never users, with
noticeable differences by sex (ORs: 17.0 [8.36, 34.78] for males, and
7.26 [3.68, 14.33] for females). The average amount of alcohol
consumed per day, smoking duration, and type of tobacco smoked
were also strongly related to an increased risk of developing
esophageal cancer. Quitting either habit reduced the risk of SCC,
although reductions in risk were only evident 10 years after alcohol
quitting [50]. These results emphasize the importance of smoking
and alcohol cessation in the reduction of esophageal cancer risk in
the Central and South American region.
It is also possible that the geographic variation in esophageal
cancer rates observed across Central and South America may, in
part, be related to other environmental and behavioral factors (i.e.
maté consumption, obesity, diet and Helicobacter pylori infection)
E. Barrios et al. / Cancer Epidemiology 44S (2016) S53–S61 S59[2,21,48,51,52] as well as improvements in disease diagnosis and
healthcare access [42].
Maté, a non-alcoholic infusion (also known as yerba mate), as
traditionally consumed in South America (drunk scalding hot
through a metal straw) is a probable cause of esophageal cancer
[40]. The suggested mechanisms for maté carcinogenicity include
thermal damage and exposure to some polycyclic aromatic
compounds (i.e. benzo[a]pyrene) detected in both hot and cold
maté infusions [53–56]. Maté is usually consumed in Argentina,
Bolivia, Brazil, Chile, Ecuador, Paraguay and Uruguay, and mainly
consumed at very high temperatures, except in Paraguay and in
southeast, northeast and north Brazil, where it is also consumed
cold [54]. In pooled analysis of two large multicenter case–control
studies in Argentina, Brazil, Paraguay, and Uruguay, Lubin et al. [55]
found that the risk of SCC linearly increased with the cumulative
maté consumption and did not vary with intensity. The association
between cumulative maté consumption was stronger with
consumption at high and very high temperatures.1
Using data from the multicenter case–control study conducted
in Argentina, Brazil, Paraguay and Uruguay, Castellsague et al. [57]
estimated that approximately 10% and 12% of the incident
esophageal SCC cases in males and females, respectively, were
attributed to consumption of very hot drinks (including maté),
assuming causal association. Although these attributable risk
estimates maybe overestimated, since consumption of other hot
foods (e.g. soups) was not considered in the analysis, they seem
consistent with the chronic thermal injury hypothesis [9]. The
relationship between maté consumption and esophageal cancer
(including SCC) deserves further investigation, particularly in the
Southern Cone of South America where we observed the highest
incidence and mortality rates from esophageal cancer.
Obesity has also been associated with an increased risk of AC;
the proposed mechanism is that obesity increasing intra-abdomi-
nal pressure thereby increases the risk of GORD and its progression
to the metaplastic precursor state of Barrett’s esophagus [17,58]. In
Latin America (including the Caribbean), 36% and 41% of the
esophageal AC cases estimated to occur in men and women,
respectively, in 2012 were attributed to high BMI (25 kg/m2),
assuming a causal relationship [48]. This is particularly relevant for
the Central and South American region because the prevalence of
overweight/obesity has steadily increased since the 1990s [59].
Although the incidence of esophageal AC is relatively low, as
obesity increases it is possible that the rates of AC will increase in
the future; therefore, continued monitoring of obesity and AC
trends in the Central and South American region are necessary in
order to evaluate this possible association.
Epidemiologic evidence suggests that infection with H. pylori
reduces the risk of esophageal AC; however, this remains
controversial [60]. H. pylori decreases gastric acidity in some
hosts by inducing atrophic corpus gastritis or by affecting the
amount of acid secreted in the stomach, and consequently may
reduce the risk of developing GORD, Barrett’s esophagus, and
esophageal AC [2,51]. The prevalence of H. pylori in Latin America
(including the Caribbean) is 30–90%, depending on the socioeco-
nomic conditions [61]. This may, in part, explain the lower
incidence of esophageal AC in the region as compared to SCC;
however, this warrants further investigation.
Certain dietary factors may play a role in the development of
esophageal cancer [2]. For example, low intake of fruits and1 Recently, a Working Group convened by IARC evaluated the carcinogenicity of
drinking coffee, maté, and very hot beverages, as part of the IARC Monographs
Programme. The Working Group found that drinking very hot (above 65 C)
beverages probably causes cancer of the oesophagus in humans. No conclusive
evidence was found for drinking maté at temperatures that are not very hot or for
drinking coffee [http://dx.doi.org/10.1016/S1470-2045(16)30239-X].vegetables, consumption of meat and processed meat and dairy
products (which may result in exposure to N-nitroso compounds)
are associated with an increased risk of SCC [2]. High consumption
of fruits, fresh vegetables, dietary ﬁber, and antioxidants, and low
consumption of fat dairy, processed food and red meat are
inversely associated with the risk of esophageal cancer [62],
including SCC, [63,64]; high consumption of ﬁsh is inversely
related with the risk of esophageal AC [65]. Latin America is
undergoing a nutritional transition denoted by a marked increase
in the consumption of total fat, animal products and sugars, and by
declines in the consumption of cereals, fruit, and some vegetables
[66]. Thus it is important to further evaluate the role of diet with
the risk of esophageal carcinoma.
The present study has several strengths and limitations. We
provide a comprehensive description of the burden of esophageal
cancer in 13Central and South America countries (48 cancer
registries), exceeding the data published in Cancer Incidence in
Five Continents (CI5) Volume X (eightcountries, 22 cancer registries)
[30] and national mortality data from 18 countries. However, our
results should be interpreted with caution because cancer incidence
data are represented by aggregated data from regional registries
which do not cover the entire country (except for Costa Rica and
Uruguay which have national coverage). Registration may also differ
in completeness and data quality due to the age and development in
maturity of the registries (i.e. Bolivia and El Salvador).
This is the ﬁrst study that describes patterns of esophageal cancer
by histological type in Central and South America. We focused only
on high-quality cancer registries (as per their inclusion in CI5) to
avoid any potential data quality issues, given that about 10% of the
cases registered in the region were not otherwise speciﬁed. It is also
possible that AC rates are under estimated due to misclassiﬁcation of
cases originating in the gastroesophageal junction [10]. This study
also underlines the need to improve cancer registrations in the
region to minimize missing or incomplete data.
5. Conclusion
Esophageal cancer incidence and mortality rates vary consid-
erably within countries in Central and South America, with the
highest burden observed in the Southern Cone of South America.
Males had remarkably higher incidence and mortality rates than
females. Esophageal SCC was the most frequently diagnosed
histological subtype in Central and South America. Declines in
incidence and mortality rates of esophageal cancer were observed
in males and females in Argentina, Brazil (incidence), Chile and
Costa Rica from 2007 to 2008; such declines may be consistent
with declines observed in Western populations which could reﬂect
changes in the prevalence of smoking and alcohol use.
The remarkable geographic variation in esophageal cancer may
be explained by different etiologies of these disease, including the
prevalence of tobacco smoking and alcohol consumption. Thus, the
implementation and/or strengthening tobacco and alcohol control
policies in the Central and South American region are likely to
reduce the burden of esophageal cancer, particularly in countries
with the highest incidence and mortality rates. However, contin-
ued monitoring of esophageal cancer trends as well as patterns of
smoking and alcohol use are necessary in order to evaluate the
impact of such measures.
The geographic variation in esophageal cancer rates may also be
related to other environmental and behavioral factors (maté
consumption, obesity, diet and H. pylori infection), but it is
important to monitor these factors and evaluate these possible
associations. Continuous monitoring of esophageal cancer rates,
including a distinction between SCC and AC, are necessary in order
to provide the basis for esophageal cancer prevention and control
in the Central and South American region.
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Annex.
Table A1.Table A1
Proportion of incidence oesophageal cancer cases by histological subtype and sex, all a
Country (Period) MALES 
SCC Adeno. Other Sp. Non spec. 
n (%) n (%) n (%) n (%) 
CENTRAL AMERICA
Costa Rica (2003-2007) 78 (58.2) 50 (37.3) 1 (0.7) 5 (3.7) 
Cuba (2004-2007)a 43 (63.2) 15 (22.1) 0 (0.0) 10 (14.7) 
El Salvador (1999-2003)a 40 (80.0) 4 (8.0) 0 (0.0) 6 (12.0) 
Mexico (2005-2010)a 33 (19.4) 127 (74.7) 2 (1.2) 8 (4.7) 
SOUTH AMERICA
Argentina (2003-2007)a 401 (54.4) 243 (33.0) 0 (0.0) 93 (12.6) 
Bolivia (2011)a 4 (40.0) 5 (50.0) 0 (0.0) 1 (10.0) 
Brazil (2003-2007)a 2543 (73.2) 572 (16.5) 20 (0.6) 337 (9.7) 
Chile (2003-2007)a 62 (64.6) 24 (25.0) 2 (2.1) 8 (8.3) 
Colombia (2003-2007)a 122 (58.7) 73 (35.1) 0 (0.0) 13 (6.3) 
Ecuador (2004-2007)a 44 (65.7) 15 (22.4) 2 (3.0) 6 (9.0) 
French Guyana (2003-2007)a 17 (85.0) 3 (15.0) 0 (0.0) 0 (0.0) 
Peru (2001-2005)a 82 (70.1) 22 (18.8) 2 (1.7) 11 (9.4) 
Uruguay (2005-2007) 288 (67.8) 93 (21.9) 8 (1.9) 36 (8.5) 
SCC, squamous cell carcinoma; Adeno., adenocarcinoma; Other Sp., Other speciﬁed; No
a Aggregated data from regional cancer registries, no national coverage.References
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